Concepedia

Gary R. Braslawsky

GR

21

Publications

1.3K

Citations

18

H-Index

1976

Active since

Affiliations

Bristol-Myers Squibb (United States)(Current)

Tel Aviv University

Oak Ridge National Laboratory

Bristol-Myers Squibb (Germany)

Biogen (United States)

Gary R. Braslawsky is an author at Bristol-Myers Squibb (United States) specializing in medicine, immunology, and immunotherapy.

Top concepts

Publications per year

1976–2006

21

Publications

21

(6-Maleimidocaproyl)hydrazone of doxorubicin. A new derivative for the preparation of immunoconjugates of doxorubicin

David Willner, Pamela A. Trail, Sandra J. Hofstead et al. · Bioconjugate Chemistry · 1993 · 222 citations

, , +17

Evaluation in vitro of adriamycin immunoconjugates synthesized using an acid-sensitive hydrazone linker.

Robert S. Greenfield, Takushi Kaneko, A Daues et al. · PubMed · 1990 · 179 citations

, , +16

New hydrazone derivatives of Adriamycin and their immunoconjugates - a correlation between acid stability and cytotoxicity

Takushi Kaneko, David Willner, Ivo Monković et al. · Bioconjugate Chemistry · 1991 · 162 citations

Adriamycin(hydrazone)-antibody conjugates require internalization and intracellular acid hydrolysis for antitumor activity

Gary R. Braslawsky, Kathleen F. Kadow, Jay O. Knipe et al. · Cancer Immunology Immunotherapy · 1991 · 80 citations · Full text

, , +5

Antitumor activity of adriamycin (hydrazone-linked) immunoconjugates compared with free adriamycin and specificity of tumor cell killing.

Gary R. Braslawsky, M A Edson, W Pearce et al. · PubMed · 1990 · 70 citations

, , +13

Rows per page

1–5 of 21